The C-terminus of murine S100A9 inhibits hyperalgesia and edema induced by jararhagin

Date
2004-01-01Author
Dale, C. S.
Goncalves, LRC
Juliano, L.
Juliano, M. A.
Silva, AMM da
Giorgi, R.
Type
ArtigoISSN
0196-9781Is part of
PeptidesDOI
10.1016/j.peptides.2003.12.008Metadata
Show full item recordAbstract
The effect of a synthetic peptide (H-92-G(110)) identical to the C-terminus of murine S100A9 (mS100A9p) was investigated on hyperalgesia and edema induced by either jararhagin or papain in the rat paw. mS100A9p not only reverted hyperalgesia and edema induced by jararhagin, but also the highest concentration induced antinociception. Hemorrhage induced by jararhagin and its hydrolytic activity were inhibited by mS100A9p. These data suggest that mS100A9p might block jararhagin-induced hyperalgesia and edema by inhibiting jararhagin catalytic activity, since papain-induced hyperalgesia and edema were not inhibited by mS100A9p. (C) 2004 Elsevier Inc. All rights reserved.
Citation
Peptides. New York: Elsevier B.V., v. 25, n. 1, p. 81-89, 2004.Keywords
hyperalgesiaedema
jararhagin
papain
MRP-14
S100A9
Collections
- EPM - Artigos [17709]